Suppr超能文献

甲状腺切除术后甲状腺功能减退患者因双氢速甾醇治疗导致的高钙血症。

Hypercalcaemia due to dihydrotachysterol treatment in patients with hypothyroidism after thyroidectomy.

作者信息

Lamberg B A, Tikkanen M J

出版信息

Br Med J (Clin Res Ed). 1981 Aug 15;283(6289):461-2. doi: 10.1136/bmj.283.6289.461.

Abstract

Hypercalcaemia is a recognised complication of hypothyroidism. We describe three patients who developed hypercalcaemia after thyroidectomy when thyroid supplements were discontinued. They were treated with thyroxine, dihydrotachysterol, and calcium after operation, and in all three cases serum calcium concentrations remained constant during combined treatment. Thyroxine treatment was discontinued several weeks before a radioiodine scan was performed; dihydrotachysterol and calcium were continued throughout. Serum calcium concentrations rose to hypercalcaemic levels in all cases. Elimination of dihydrotachysterol from plasma may be delayed in hypothyroidism, resulting in hypervitaminosis D. It is advisable to reduce the dose of dihydrotachysterol and to check serum calcium concentrations regularly in patients whose thyroid treatment is interrupted.

摘要

高钙血症是甲状腺功能减退症的一种公认并发症。我们描述了3例患者,他们在甲状腺切除术后停用甲状腺补充剂后出现了高钙血症。术后他们接受了甲状腺素、双氢速甾醇和钙剂治疗,在所有3例患者中,联合治疗期间血清钙浓度保持稳定。在进行放射性碘扫描前几周停用了甲状腺素治疗;双氢速甾醇和钙剂则一直持续使用。所有病例中血清钙浓度均升至高钙血症水平。甲状腺功能减退症患者血浆中双氢速甾醇的清除可能会延迟,从而导致维生素D过多症。对于甲状腺治疗中断的患者,建议减少双氢速甾醇的剂量并定期检查血清钙浓度。

相似文献

1
Hypercalcaemia due to dihydrotachysterol treatment in patients with hypothyroidism after thyroidectomy.
Br Med J (Clin Res Ed). 1981 Aug 15;283(6289):461-2. doi: 10.1136/bmj.283.6289.461.
2
Hypercalcaemia induced by increased thyroxine substitution in a patient treated with dihydrotachysterol.
Acta Endocrinol (Copenh). 1984 Jan;105(1):28-30. doi: 10.1530/acta.0.1050028.
3
Unaccountable severe hypercalcemia in a patient treated for hypoparathyroidism with dihydrotachysterol.
Neth J Med. 1999 Jan;54(1):16-20. doi: 10.1016/s0300-2977(98)00133-8.
5
[Dihydrotachysterol poisoning].
Z Gesamte Inn Med. 1984 Oct 15;39(20):511-3.
6
[Hypercalcemia].
Praxis (Bern 1994). 2003 Sep 17;92(38):1567-71. doi: 10.1024/0369-8394.92.38.1567.
8
Dihydrotachysterol therapy for hypoparathyroidism: consequences of inadequate monitoring. Five cases and a review.
Exp Clin Endocrinol Diabetes. 2005 Jul;113(7):376-80. doi: 10.1055/s-2005-865724.
10
Hypercalcaemia and renal failure following long-term treatment with dihydrotachysterol (AT 10).
Acta Med Scand. 1959 Mar 4;163(3):257-63. doi: 10.1111/j.0954-6820.1959.tb10406.x.

引用本文的文献

1
Calcium metabolism in thyroid disease.
J Endocrinol Invest. 1988 Jan;11(1):61-9. doi: 10.1007/BF03350101.

本文引用的文献

1
Hypercalcemia in myxedema.
J Clin Endocrinol Metab. 1962 Mar;22:261-7. doi: 10.1210/jcem-22-3-261.
2
Influence of thyroid function on the serum concentration of 1,25-dihydroxyvitamin D3.
J Clin Endocrinol Metab. 1980 Oct;51(4):793-7. doi: 10.1210/jcem-51-4-793.
3
The influence of thyroid hormone on calcium absorption from the gut in relation to urinary calcium excretion.
Acta Endocrinol (Copenh). 1973 Aug;73(4):672-80. doi: 10.1530/acta.0.0730672.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验